PROM1 and neoplasm: Moreover, CD133 is mainly expressed in well- and moderately-differentiated adenocarcinomas, and CD133 negativity may reflect tumour ‘budding’, a more undifferentiated state at the front of invasion where tumour cells are known to almost always be CD133 negative[14], [59].